Although previous experimental studies have implied that α6β4 integrin facilitates tumor progression by regulating growth factor receptors signaling [15], to our knowledge this is the first study demonstrating an in vivo correlation between β4 and ErbB-3 expression suggesting that β4 can regulate ErbB-3 protein in vivo and favor indirectly tumor progression. The gene discussed is ERBB3; the disease is neoplasm.